High costs of orphan drugs: Patients pay the price for policy hurdles in India 0 24.06.2024 11:08 Economictimes.indiatimes.com India manufactures APIs for over 400 FDA-approved orphan drugs, but patients face high costs due to Indian pharma companies' reluctance to develop these drugs domestically. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
